Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

6,677 evidence items · page 23 / 268

75 %Aflatoxin B1 was detected in 6 of 8 women living with HIV with detectable HIV viral load (75.0%).

KenyaVIH/sidapublished 2025International journal of STD & AIDSPubMeddocument of 8 observations

81 %HSV-2 prevalence was 81% among HIV-1 seronegative sex workers from Mombasa, Kenya.

Kenyaherpes simplex virus-2published 2007AIDS (London, England)europe_pmcdocument of 6 observationsDOI 10.1097/qad.0b013e328270388a

9 %Meningitis or encephalitis was present in 15 (9%) of 162 HIV-attributed infant or child deaths.

Kenyameningitis or encephalitis · VIH/sidaobserved Dec 3, 2016 to Dec 31, 2024published 2026The lancet. HIVPubMeddocument of 23 observations

3.4 yearsThe median estimated time since HIV infection (ETI) among adolescent girls and young women who self-identify as female sex workers in Mombasa, Kenya, was 3.4 years.

KenyaVIH/sidapublished 2023AIDS (London, England)PubMeddocument of 3 observations

99 %Uptake of cotrimoxazole prophylaxis among TB/HIV co-infected patients was 99%.

Kenyatuberculose · VIH/sidaobserved 2012–2020published 2023BMC infectious diseasesPubMeddocument of 11 observations

380 US$ per year-of-life-savedPaclitaxel has an incremental cost-effectiveness ratio of US$380 per year-of-life-saved compared with bleomycin-vincristine for advanced AIDS-associated Kaposi sarcoma in Kenya.

Kenyaadvanced AIDS-associated Kaposi sarcomapublished 2022The Lancet. Global healthPubMeddocument of 5 observations

12 per_317Among 317 women, CIN1 cases included HPV81 in 12/317 (3.8%) and HPV11 in 2/317 (0.6%).

KenyaCIN1published 2021BioMed research internationalPubMeddocument of 9 observations

16 %Among 67 transfeminine participants, eight (16%) reported current symptoms consistent with a rectal STI.

Kenyasexually transmitted infection (STI)observed 2017published 2021The lancet. HIVPubMeddocument of 14 observations

27.1 %At 36 months, loss to follow-up among patients initiated on antiretroviral therapy in central Kenya was 27.1%.

KenyaVIH/sidaobserved 36 monthspublished 2022BMC infectious diseasesPubMeddocument of 10 observations

3,646 partnersFrom March to December 2021, 3646 partners were eligible for HIV testing.

KenyaVIH/sidaobserved March to December 2021published 2024Journal of the International AIDS SocietyPubMeddocument of 15 observations

51.1 %Just over half of publications on adolescent sexual and reproductive health in sub-Saharan Africa had authors with African institutional affiliations as first authors (51.1%).

Kenyaadolescent sexual and reproductive healthpublished 2021BMJ global healthPubMeddocument of 12 observations

85 %Malaria testing services were available at more than 85% of facilities.

Kenyapaludismepublished 2022Malaria journaleurope_pmcdocument of 10 observationsDOI 10.1186/s12936-022-04048-2

57 %Among 731 HIV-negative participants in the Maisha Fiti cohort of women who sell sex in Nairobi, Kenya, 414 (57%) were HSV-2 seropositive.

KenyaHerpes simplex virus type 2published 2026American journal of reproductive immunology (New York, N.Y. : 1989)PubMeddocument of 3 observations

Superinfected women had a trend for increased viral load at superinfection acquisition (P = 0.09).

KenyaVIH/sidapublished 2014AIDS (London, England)europe_pmcdocument of 6 observations

230,174 individualsPlasmodium falciparum prevalence data covered an examination of 230,174 individuals located in northern Namibia.

Kenyapaludismeobserved 1969–1992published 2013PloS oneeurope_pmcdocument of 6 observations

5.4 per_1000The mean incidence of Plasmodium vivax in 2009 was 5.4 cases per 1000 population.

Kenyapaludismeobserved 2009published 2014PloS oneeurope_pmcdocument of 7 observations

58 %Only 94 (58%) of 162 HIV-attributed cases had documented antemortem diagnoses.

KenyaVIH/sidaobserved Dec 3, 2016 to Dec 31, 2024published 2026The lancet. HIVPubMeddocument of 23 observations

The introduction of insecticide-treated bed nets during a randomized controlled trial on the Kenyan coast significantly reduced severe, life-threatening malaria and all-cause childhood mortality.

Kenyapaludismepublished 1997Acta tropicaeurope_pmcdocument of 4 observations

2 %2% of the population in Kenya has diabetes mellitus.

Kenyadiabète (non précisé)published 2021The Pan African medical journalPubMeddocument of 3 observations

23 %At baseline, 23.0% of older adults living with HIV in western Kenya were hypertensive.

Kenyahypertension artériellepublished 2026BMC cardiovascular disordersPubMeddocument of 6 observations

8.8 %Interventions that prevent future violence without mitigating the effects of past violence may prevent a median of 8.8% of HIV infections over 10 years in female sex workers and their clients in Mombasa, Kenya.

KenyaVIH/sidaobserved 10 yearspublished 2024BMC medicinePubMeddocument of 9 observations

8 %National malaria prevalence in Kenya was 8% in 2018.

Kenyapaludismeobserved 2018published 2022Malaria journalPubMeddocument of 8 observations

3 foldMalaria prevalence is three-fold higher in western Kenya than the national average of 6%.

Kenyapaludismepublished 2023Malaria journalPubMeddocument of 8 observations

4 %Among adolescent girls and young women seeking contraceptive services at four public sector family planning clinics in Kisumu, Kenya, from October 2018 to June 2019, 4% initiated pre-exposure prophylaxis (PrEP) at their current family planning visit.

KenyaVIH/sidaobserved October 2018 to June 2019published 2020AIDS patient care and STDsPubMeddocument of 10 observations

3 %Among adolescents living with HIV in Kenya, 3% reported no longer being able to get medication refills due to COVID-19.

KenyaCOVID-19published 2021AIDS and behaviorPubMeddocument of 6 observations

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.